Vietnam Health Minister Calls For Greater Drug Industry Regulation
This article was originally published in PharmAsia News
Vietnamese health officials called for more regulation of the country's pharmaceutical industry. In a meeting of local authorities on rising drug prices, some attendees noted Vietnamese drug makers import 90 percent of their raw materials and satisfy only half of the local demand for medicines, most for relatively minor illnesses. Health Minister Nguyen Quoc Trieu, who addressed the conference, said drug prices are high in the country in part because of a lax regulation and bad distribution systems. He called for greater regulation, particularly for specific and rare medicines. (Click here for more
You may also be interested in...
Mexico's Genomma Lab recorded strong double-digit growth for its OTC business in the second quarter as sales more than doubled at its US consumer health operation.
New board directors named at Autolus Therapeutics, Beximco Pharmaceuticals, Tetraphase Pharmaceuticals and Vesigen.
After launching a biosimilar to Avastin (bevacizumab) in India, Cadila Pharma has now also launched rituximab and teriparatide biosimilars in its domestic market.